(rac)-4-(3-(4-methyl-5-(pyridin-4-yl)-4H-1,2,4-triazol-3-ylthio)propyl)-2-(4-(trifluoromethyl)phenyl)morpholine

ID: ALA3763200

Chembl Id: CHEMBL3763200

PubChem CID: 127040697

Max Phase: Preclinical

Molecular Formula: C22H24F3N5OS

Molecular Weight: 463.53

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  Cn1c(SCCCN2CCOC(c3ccc(C(F)(F)F)cc3)C2)nnc1-c1ccncc1

Standard InChI:  InChI=1S/C22H24F3N5OS/c1-29-20(17-7-9-26-10-8-17)27-28-21(29)32-14-2-11-30-12-13-31-19(15-30)16-3-5-18(6-4-16)22(23,24)25/h3-10,19H,2,11-15H2,1H3

Standard InChI Key:  QSGQMVZHKGEIIG-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA3763200

    ---

Associated Targets(Human)

DRD3 Tclin Dopamine D3 receptor (14368 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
DRD2 Tclin Dopamine D2 receptor (23596 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
KCNH2 Tclin HERG (29587 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Drd3 Dopamine D3 receptor (1050 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Drd3 Dopamine receptor D2 and D3 (225 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 463.53Molecular Weight (Monoisotopic): 463.1654AlogP: 4.45#Rotatable Bonds: 7
Polar Surface Area: 56.07Molecular Species: NEUTRALHBA: 7HBD:
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 6.84CX LogP: 3.66CX LogD: 3.55
Aromatic Rings: 3Heavy Atoms: 32QED Weighted: 0.38Np Likeness Score: -2.03

References

1. Micheli F, Cremonesi S, Semeraro T, Tarsi L, Tomelleri S, Cavanni P, Oliosi B, Perdonà E, Sava A, Zonzini L, Feriani A, Braggio S, Heidbreder C..  (2016)  Novel morpholine scaffolds as selective dopamine (DA) D3 receptor antagonists.,  26  (4): [PMID:26786693] [10.1016/j.bmcl.2015.12.081]

Source